Association of Low Body Weight with Clinical Outcomes in Elderly Atrial Fibrillation Patients Receiving Apixaban —J-ELD AF Registry Subanalysis

ConclusionsThe incidence of events in each body weight group was comparable for stroke or systemic embolism and bleeding requiring hospitalization, and body weight<50 kg might not be an independent risk for death in Japanese non-valvular AF patients aged ≥ 75 years taking on-label doses of apixaban.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research